BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guruvayoorappan C. Tumor versus tumor-associated macrophages: how hot is the link? Integr Cancer Ther. 2008;7:90-95. [PMID: 18550889 DOI: 10.1177/1534735408319060] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Song S, Zhang Y, Duan X, Liu C, Du Y, Wang X, Luo Y, Cui Y. HIF-1α/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression. Cancer Gene Ther 2022. [DOI: 10.1038/s41417-022-00551-5] [Reference Citation Analysis]
2 Baharun BNB, Safuan S, Abdullah NA, Selvam K, Nor Hisham SR. The influence of macrophage polarisation status and IL-6 in breast carcinoma invasion. Revista de Senología y Patología Mamaria 2022;35:100-108. [DOI: 10.1016/j.senol.2021.11.002] [Reference Citation Analysis]
3 Habanjar O, Diab-assaf M, Caldefie-chezet F, Delort L. The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis. Biology 2022;11:339. [DOI: 10.3390/biology11020339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Karim MR, Hossain D, Uddin AM, Rume FI. Role of macrophages in tumor development. Recent Advancements in Microbial Diversity 2022. [DOI: 10.1016/b978-0-12-822368-0.00007-4] [Reference Citation Analysis]
5 He Z, Zhang S. Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment. Front Immunol 2021;12:741305. [PMID: 34603327 DOI: 10.3389/fimmu.2021.741305] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
6 Ten Voorde AMW, Wierenga APA, Nell RJ, van der Velden PA, Luyten GPM, Verdijk RM, Jager MJ. In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target. Cancers (Basel) 2021;13:3986. [PMID: 34439141 DOI: 10.3390/cancers13163986] [Reference Citation Analysis]
7 Munir MT, Kay MK, Kang MH, Rahman MM, Al-Harrasi A, Choudhury M, Moustaid-Moussa N, Hussain F, Rahman SM. Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth. Int J Mol Sci 2021;22:6526. [PMID: 34207035 DOI: 10.3390/ijms22126526] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
8 Sandoval Pacheco CM, Araujo Flores GV, Gonzalez K, de Castro Gomes CM, Passero LFD, Tomokane TY, Sosa-Ochoa W, Zúniga C, Calzada J, Saldaña A, Corbett CEP, Silveira FT, Laurenti MD. Macrophage Polarization in the Skin Lesion Caused by Neotropical Species of Leishmania sp. J Immunol Res 2021;2021:5596876. [PMID: 33937417 DOI: 10.1155/2021/5596876] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
9 Kabasawa T, Ohe R, Aung NY, Urano Y, Kitaoka T, Tamazawa N, Utsunomiya A, Yamakawa M. Potential role of M2 TAMs around lymphatic vessels during lymphatic invasion in papillary thyroid carcinoma. Sci Rep 2021;11:1150. [PMID: 33441903 DOI: 10.1038/s41598-020-80694-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Ball MS, Bhandari R, Torres GM, Martyanov V, ElTanbouly MA, Archambault K, Whitfield ML, Liby KT, Pioli PA. CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer. Sci Rep 2020;10:6560. [PMID: 32300202 DOI: 10.1038/s41598-020-63482-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
11 Hu H, Tu W, Chen Y, Zhu M, Jin H, Huang T, Zou Z, Xia Q. The combination of PKM2 overexpression and M2 macrophages infiltration confers a poor prognosis for PDAC patients. J Cancer 2020;11:2022-31. [PMID: 32127930 DOI: 10.7150/jca.38981] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
12 Cao L, Che X, Qiu X, Li Z, Yang B, Wang S, Hou K, Fan Y, Qu X, Liu Y. M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer. Cancer Manag Res 2019;11:6125-38. [PMID: 31308749 DOI: 10.2147/CMAR.S199832] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
13 Sánchez-Reyes K, Pedraza-Brindis EJ, Hernández-Flores G, Bravo-Cuellar A, López-López BA, Rosas-González VC, Ortiz-Lazareno PC. The supernatant of cervical carcinoma cells lines induces a decrease in phosphorylation of STAT-1 and NF-κB transcription factors associated with changes in profiles of cytokines and growth factors in macrophages derived from U937 cells. Innate Immun 2019;25:344-55. [PMID: 31099286 DOI: 10.1177/1753425919848841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
14 Mousavi-Niri N, Naseroleslami M, Hadjati J. Anti-regulatory T cell vaccines in immunotherapy: focusing on FoxP3 as target. Hum Vaccin Immunother 2019;15:620-4. [PMID: 30633616 DOI: 10.1080/21645515.2018.1545625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Wunderlich R, Rühle PF, Deloch L, Rödel F, Fietkau R, Gaipl US, Frey B. Ionizing radiation reduces the capacity of activated macrophages to induce T-cell proliferation, but does not trigger dendritic cell-mediated non-targeted effects. International Journal of Radiation Biology 2019;95:33-43. [DOI: 10.1080/09553002.2018.1490037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, Kim SJ, Lee SH. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion. PLoS One 2018;13:e0200341. [PMID: 30005083 DOI: 10.1371/journal.pone.0200341] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
17 Wu Y, Zhong C, Du T, Qiu J, Xiong M, Hu Y, Chen Y, Li Y, Liu B, Liu Y, Zou B, Jiang S, Gou M. Preparation and characterization of yeast-encapsulated doxorubicin microparticles. Journal of Drug Delivery Science and Technology 2018;45:442-8. [DOI: 10.1016/j.jddst.2018.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Jiang C, Cai H, Peng X, Zhang P, Wu X, Tian R. Targeted Imaging of Tumor-Associated Macrophages by Cyanine 7-Labeled Mannose in Xenograft Tumors. Mol Imaging 2017;16:1536012116689499. [PMID: 28654380 DOI: 10.1177/1536012116689499] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
19 Zúñiga-Castillo M, Pereira NV, Sotto MN. High density of M2-macrophages in acral lentiginous melanoma compared to superficial spreading melanoma. Histopathology 2018;72:1189-98. [PMID: 29415335 DOI: 10.1111/his.13478] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Bessler H, Djaldetti M. Broccoli and human health: immunomodulatory effect of sulforaphane in a model of colon cancer. International Journal of Food Sciences and Nutrition 2018;69:946-53. [DOI: 10.1080/09637486.2018.1439901] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
21 Mansoori B, Mohammadi A, Shirjang S, Baradaran B. MicroRNAs in the Diagnosis and Treatment of Cancer. Immunological Investigations 2017;46:880-97. [DOI: 10.1080/08820139.2017.1377407] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
22 Faas MM, de Vos P. Uterine NK cells and macrophages in pregnancy. Placenta 2017;56:44-52. [DOI: 10.1016/j.placenta.2017.03.001] [Cited by in Crossref: 146] [Cited by in F6Publishing: 154] [Article Influence: 29.2] [Reference Citation Analysis]
23 Binnemars-Postma K, Storm G, Prakash J. Nanomedicine Strategies to Target Tumor-Associated Macrophages. Int J Mol Sci 2017;18:E979. [PMID: 28471401 DOI: 10.3390/ijms18050979] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
24 Martinez-Marin D, Jarvis C, Nelius T, de Riese W, Volpert OV, Filleur S. PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro. PLoS One 2017;12:e0174968. [PMID: 28403150 DOI: 10.1371/journal.pone.0174968] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
25 Nixon AM, Connor JR. Does HFE Genotype Impact Macrophage Phenotype in Disease Process and Therapeutic Response? Biometals in Neurodegenerative Diseases 2017. [DOI: 10.1016/b978-0-12-804562-6.00004-x] [Reference Citation Analysis]
26 Santana CH, Moreira PRR, Rosolem MC, Vasconcelos RO. Relationship between the inflammatory infiltrate and the degree of differentiation of the canine cutaneous squamous cell carcinoma. Vet Anim Sci 2016;1-2:4-8. [PMID: 32734017 DOI: 10.1016/j.vas.2016.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014;6:1670-1690. [PMID: 25125485 DOI: 10.3390/cancers6031670] [Cited by in Crossref: 899] [Cited by in F6Publishing: 968] [Article Influence: 112.4] [Reference Citation Analysis]
28 Yan L, Gao Y, Pierce R, Dai L, Kim J, Zhang M. Development of Y-shaped peptide for constructing nanoparticle systems targeting tumor-associated macrophages in vitro and in vivo. Mater Res Express 2014;1:025007. [DOI: 10.1088/2053-1591/1/2/025007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
29 Fraser CK, Brown MP, Diener KR, Hayball JD. Unravelling the complexity of cancer–immune system interplay. Expert Review of Anticancer Therapy 2014;10:917-34. [DOI: 10.1586/era.10.66] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ribatti D, Moschetta M, Vacca A. Macrophages in multiple myeloma. Immunol Lett 2014;161:241-4. [PMID: 24370642 DOI: 10.1016/j.imlet.2013.12.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
31 Shathish K, Guruvayoorappan C. Decalepis hamiltonii inhibits tumor progression and metastasis by regulating the inflammatory mediators and nuclear factor κB subunits. Integr Cancer Ther 2014;13:141-51. [PMID: 24013642 DOI: 10.1177/1534735413502075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
32 Lakshmi Narendra B, Eshvendar Reddy K, Shantikumar S, Ramakrishna S. Immune system: a double-edged sword in cancer. Inflamm Res. 2013;62:823-834. [PMID: 23868500 DOI: 10.1007/s00011-013-0645-9] [Cited by in Crossref: 99] [Cited by in F6Publishing: 112] [Article Influence: 11.0] [Reference Citation Analysis]
33 Yang Y, Zhang R, Xia F, Zou T, Huang A, Xiong S, Zhang J. LPS converts Gr-1(+)CD115(+) myeloid-derived suppressor cells from M2 to M1 via P38 MAPK. Exp Cell Res 2013;319:1774-83. [PMID: 23701951 DOI: 10.1016/j.yexcr.2013.05.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
34 Ochando JC, Chen SH. Myeloid-derived suppressor cells in transplantation and cancer. Immunol Res 2012;54:275-85. [PMID: 22535241 DOI: 10.1007/s12026-012-8335-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
35 Wierstra I. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy. Adv Cancer Res 2013;119:191-419. [PMID: 23870513 DOI: 10.1016/B978-0-12-407190-2.00016-2] [Cited by in Crossref: 111] [Cited by in F6Publishing: 79] [Article Influence: 12.3] [Reference Citation Analysis]
36 Gomes FG, Nedel F, Alves AM, Nör JE, Tarquinio SB. Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms. Life Sci. 2013;92:101-107. [PMID: 23178150 DOI: 10.1016/j.lfs.2012.10.008] [Cited by in Crossref: 83] [Cited by in F6Publishing: 95] [Article Influence: 8.3] [Reference Citation Analysis]
37 Zhang J, Yang Z, Xie L, Xu L, Xu D, Liu X. Statins, autophagy and cancer metastasis. Int J Biochem Cell Biol. 2013;45:745-752. [PMID: 23147595 DOI: 10.1016/j.biocel.2012.11.001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 6.9] [Reference Citation Analysis]
38 Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012;2012:948098. [PMID: 22778768 DOI: 10.1155/2012/948098] [Cited by in Crossref: 499] [Cited by in F6Publishing: 587] [Article Influence: 49.9] [Reference Citation Analysis]
39 Pienta KJ, McGregor N, Axelrod R, Axelrod DE. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Transl Oncol 2008;1:158-64. [PMID: 19043526 DOI: 10.1593/tlo.08178] [Cited by in Crossref: 112] [Cited by in F6Publishing: 125] [Article Influence: 10.2] [Reference Citation Analysis]
40 Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T, Chen SH. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 2011;34:385-95. [PMID: 21376641 DOI: 10.1016/j.immuni.2011.02.004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 117] [Article Influence: 10.0] [Reference Citation Analysis]
41 Vergati M, Schlom J, Tsang KY. The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring. J Biomed Biotechnol 2011;2011:182413. [PMID: 21318157 DOI: 10.1155/2011/182413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
42 Li DY, Chen XP. Correlation between ANGPTL3 expression and tumor angiogenesis in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(32): 3471-3475 [DOI: 10.11569/wcjd.v18.i32.3471] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Lowe EL, Crother TR, Rabizadeh S, Hu B, Wang H, Chen S, Shimada K, Wong MH, Michelsen KS, Arditi M. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS One. 2010;5:e13027. [PMID: 20885960 DOI: 10.1371/journal.pone.0013027] [Cited by in Crossref: 109] [Cited by in F6Publishing: 115] [Article Influence: 9.1] [Reference Citation Analysis]
44 Arismendi-morillo G, Castellano-ramírez A, Medina Z. Ultrastructural Characterization of Macrophage-like Mononuclear Leukocytes in Human Astrocytic Tumors. Ultrastructural Pathology 2010;34:321-6. [DOI: 10.3109/01913123.2010.487972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Zhang H, Ma Y, Sun XL. Recent developments in carbohydrate-decorated targeted drug/gene delivery. Med Res Rev 2010;30:270-89. [PMID: 19626595 DOI: 10.1002/med.20171] [Cited by in Crossref: 11] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
46 Lin H, He ZL, Zhong DW. Clinical significance of survivin expression in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(16): 1676-1681 [DOI: 10.11569/wcjd.v18.i16.1676] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
47 Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 2009;22:1376-85. [PMID: 19645497 DOI: 10.1021/tx900086v] [Cited by in Crossref: 198] [Cited by in F6Publishing: 180] [Article Influence: 16.5] [Reference Citation Analysis]
48 Butchar JP, Mehta P, Justiniano SE, Guenterberg KD, Kondadasula SV, Mo X, Chemudupati M, Kanneganti TD, Amer A, Muthusamy N, Jarjoura D, Marsh CB, Carson WE 3rd, Byrd JC, Tridandapani S. Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy. Clin Cancer Res 2010;16:2065-75. [PMID: 20332325 DOI: 10.1158/1078-0432.CCR-09-2591] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
49 McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA. Leukocytic promotion of prostate cellular proliferation. Prostate 2010;70:377-89. [PMID: 19866464 DOI: 10.1002/pros.21071] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
50 Laskin D, Gardner C, Laskin J. Phagocytes. Comprehensive Toxicology. Elsevier; 2010. pp. 133-53. [DOI: 10.1016/b978-0-08-046884-6.00607-2] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol. 2009;9:65. [PMID: 19732435 DOI: 10.1186/1471-230x-9-65] [Cited by in Crossref: 107] [Cited by in F6Publishing: 119] [Article Influence: 8.2] [Reference Citation Analysis]
52 Bergers G. Bone Marrow-Derived Cells in GBM Neovascularization. In: Meir EG, editor. CNS Cancer. Totowa: Humana Press; 2009. pp. 749-73. [DOI: 10.1007/978-1-60327-553-8_31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]